• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Anti-cancer effect of disrupting the transcription coupled repair gene, CSB

    Thumbnail
    Date
    2002
    Author
    Lu, Yi
    Metadata
    Show full item record
    Abstract
    Certain DNA lesions when present in the transcribed strand of active genes are repaired faster than those located elsewhere. This phenomenon, transcription-coupled repair (TCR), is defective in cells from individuals with Cockayne syndrome (CS), which have two complementation groups, CSA and CSB. CSB is a DNA-dependent ATPase in the SNF2 family that remodels chromatin and stimulates transcript elongation by RNAP II CSB protein might function in rearranging interactions between RNAP II and damaged DNA, thus allowing the DNA repair apparatus to gain access to DNA lesions.;Despite their DNA repair defect, CS patients do not demonstrate an elevated cancer incidence, in drastic contrast with individuals defective with other kinds of DNA repair. To study the effect of CSB disruption on carcinogenesis, we crossed CSB-/- mice with cancer prone mice lacking the p16 INK4a/p19ARF tumor suppressor locus. CSB-/- Ink4a/ARF-/- mice developed 60% fewer tumors than Ink4a/ARF-/- mice and demonstrated a longer tumor-free latency time (260 versus 150 days). Moreover, CSB-/- Ink4a/ARF-/- mouse embryo fibroblast (MEFs) exhibited a lower colony formation rate, a lower rate of H-Ras-induced transformation, slower proliferation, a lower mRNA synthesis rate, increased UV-induced p53 and apoptosis than Ink4a/ARF-/- MEFs. These results indicate that the antineoplastic effect of CSB gene disruption may result from impaired transcription or from apoptosis secondary to environmental or endogenous DNA damage.;To investigate the potential use of CSB disruption in cancer chemotherapy, we designed and characterized phosphorothioate antisense oligodeoxynucleotides (AOs) that reduced CSB mRNA level in A2780/CP70 ovarian carcinoma cells. The AOs caused the cells to proliferate more slowly and made them more sensitive to cisplatin, oxaliplatin, hydrogen peroxide and gamma-irradiation, all of which induce lesions that are subject to TCR. Chemically modified AOs (MBOs) targeting CSB were able to potentiate the anti-tumor effect of cisplatin against A2780/CP70 tumor xenografts formed in nude mice. The MBOs enabled a non-toxic (3 mg/kg) dose of cisplatin to have the same degree of anti-tumor efficacy as a more toxic (5 mg/kg) cisplatin dose.;Collectively, CSB gene disruption increased DNA-damage induced apoptosis, decreased spontaneous tumorigenesis in vivo, and might be a novel target for cancer chemotherapy.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:3061788
    https://hdl.handle.net/20.500.12202/595
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University